04/30/2024
2:25 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/26/2024
4:10 PM | Olema Pharmaceuticals (Filer)
| Form DEFA14A | |
04/26/2024
4:15 PM | Olema Pharmaceuticals (Filer)
| Form ARS | |
03/29/2024
4:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2024
10:02 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024
3:31 PM | Deep Track Capital, LP (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G | |
03/20/2024
4:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/11/2024
3:31 PM | Olema Pharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/11/2024
3:15 PM | Olema Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
4:36 PM | Olema Pharmaceuticals (Issuer)
RAPPAPORT ANDREW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/29/2024
1:26 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
11:53 AM | Kynam Capital Management, LP (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/12/2024
4:16 PM | Olema Pharmaceuticals (Filer)
| Form 424B3 | |
02/12/2024
11:21 AM | JANUS HENDERSON GROUP PLC (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G/A | |
02/11/2024
11:15 PM | Olema Pharmaceuticals (Filer)
| Form EFFECT | |
02/05/2024
4:30 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/05/2024
4:30 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
4:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2024
2:24 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/31/2024
1:58 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13G | |
01/29/2024
6:30 AM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
6:30 AM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
8:07 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/08/2024
7:18 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/05/2024
4:25 PM | Olema Pharmaceuticals (Filer)
| Form 424B5 | |
01/05/2024
4:26 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/02/2024
4:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
5:30 PM | Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:55 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
4:55 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/08/2023
3:19 PM | Asefaw Senai (Reporting)
Olema Pharmaceuticals (Issuer)
Paradigm BioCapital Advisors GP LLC (Reporting)
Paradigm Biocapital Advisors LP (Reporting)
Paradigm BioCapital International Fund Ltd. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
7:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 3/A | |
12/07/2023
7:30 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2023
6:48 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/05/2023
4:15 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/01/2023
4:15 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/30/2023
9:20 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Forget AI, Imperium Is Expected to Grow 320,00% in 3 Years (Ad) If you think AI is big, then you have got to check out something I call Imperium…
By my calculations, it’s set to grow 320,000% in three years. (You can see my calculations here.) Watch my video for all of the details |
11/22/2023
6:00 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Olema Pharmaceuticals (Issuer)
Zojwalla Naseem (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
6:00 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2023
2:25 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
2:04 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
2:12 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
1:35 PM | Olema Pharmaceuticals (Subject)
Zojwalla Naseem (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/22/2023
1:42 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
2:11 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
2:16 PM | Bohen Sean (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
1:49 PM | Kovacs Shane William Charles (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/21/2023
1:52 PM | Olema Pharmaceuticals (Subject)
Zojwalla Naseem (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/13/2023
4:30 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
8:39 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/03/2023
3:53 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
7:50 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
3:46 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/02/2023
3:21 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/01/2023
3:49 PM | Myles David C. (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2023
9:38 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/23/2023
6:45 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/18/2023
3:46 PM | Olema Pharmaceuticals (Filer)
| Form 8-K/A | |
10/17/2023
3:42 PM | Garland J. Scott (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/17/2023
3:43 PM | Garland J. Scott (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/17/2023
6:33 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/10/2023
6:17 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/29/2023
10:05 AM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/21/2023
4:12 PM | Asefaw Senai (Reporting)
Olema Pharmaceuticals (Issuer)
Paradigm BioCapital Advisors GP LLC (Reporting)
Paradigm Biocapital Advisors LP (Reporting)
Paradigm BioCapital International Fund Ltd. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
09/14/2023
3:23 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
Olema Pharmaceuticals (Subject)
| Form SC 13D/A | |
09/14/2023
3:25 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/14/2023
3:14 PM | Olema Pharmaceuticals (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/13/2023
4:22 PM | Olema Pharmaceuticals (Subject)
Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G/A | |
09/05/2023
8:08 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2023
3:05 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4/A | |
09/05/2023
12:42 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2023
6:39 AM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2023
3:37 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/20/2023
11:22 AM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2023
1:54 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/29/2023
3:36 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2023
3:40 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/27/2023
3:49 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2023
6:14 PM | BIOTECHNOLOGY VALUE FUND II LP (Reporting)
BIOTECHNOLOGY VALUE FUND L P (Reporting)
Biotechnology Value Trading Fund OS LP (Reporting)
BVF GP HOLDINGS LLC (Reporting)
BVF I GP LLC (Reporting)
BVF II GP LLC (Reporting)
BVF INC/IL (Reporting)
BVF PARTNERS L P/IL (Reporting)
BVF Partners OS Ltd. (Reporting)
LAMPERT MARK N (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Olema Pharmaceuticals (Issuer)
RAPPAPORT ANDREW (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | BUTITTA CYNTHIA M (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Graham G. Walmsley (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Hrustanovic Gorjan (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | Horning Sandra (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Biden to Launch “FedNOW” [Move Your Money Now] (Ad) Earlier this year President Biden signed the death warrant for America…
Executive Order 14067 will essentially cancel your money.
You see Biden and the Fed have teamed up to create a controllable, traceable, programmable digital currency to replace the dollar... Get your free information kit NOW, before it's too late. |
06/21/2023
4:00 PM | Larson Yi (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
4:00 PM | CLARK IAN T (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/21/2023
3:31 PM | Olema Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:23 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023
3:28 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/12/2023
4:53 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/09/2023
4:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/09/2023
4:58 PM | Moriarty John B (Reporting)
Olema Pharmaceuticals (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023
8:30 PM | Harmon Cyrus (Reporting)
Olema Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
